These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38301841)

  • 1. Risk assessment and predictors of the exposure to polycyclic aromatic hydrocarbons in Spanish adults by urinary human biomonitoring.
    Peris-Camarasa B; Pardo O; Fernández SF; Dualde P; Coscollà C
    Chemosphere; 2024 Mar; 352():141330. PubMed ID: 38301841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's exposure to polycyclic aromatic hydrocarbons in the Valencian Region (Spain): Urinary levels, predictors of exposure and risk assessment.
    Fernández SF; Pardo O; Hernández CS; Garlito B; Yusà V;
    Environ Int; 2021 Aug; 153():106535. PubMed ID: 33831740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring of polycyclic aromatic hydrocarbons in the urine of lactating mothers: Urinary levels, association with lifestyle factors, and risk assessment.
    F Fernández S; Pardo O; Pastor A; Yusà V;
    Environ Pollut; 2021 Jan; 268(Pt B):115646. PubMed ID: 33038574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for polycyclic aromatic hydrocarbons in human excreta: recent advances in analytical techniques-a review.
    Styszko K; Pamuła J; Pac A; Sochacka-Tatara E
    Environ Geochem Health; 2023 Oct; 45(10):7099-7113. PubMed ID: 37530922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supported liquid extraction and ultra-high performance liquid chromatography-tandem mass spectrometry for the determination of urinary polycyclic aromatic hydrocarbon metabolites and their application for human biomonitoring.
    Deng F; Guo C; Zeng W; Zhong Y; Luo X; Pan X; Zhang L; Tan L
    J Pharm Biomed Anal; 2023 Feb; 224():115201. PubMed ID: 36549260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of monohydroxylated polycyclic aromatic hydrocarbons in Brazilian children and health risk assessment: a human biomonitoring-based study.
    Souza MCO; Rocha BA; Ximenez JPB; Devóz PP; Santana A; Campíglia AD; Barbosa F
    Environ Sci Pollut Res Int; 2022 Jul; 29(31):47298-47309. PubMed ID: 35178633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary monohydroxylated polycyclic aromatic hydrocarbons in the general population from 26 provincial capital cities in China: Levels, influencing factors, and health risks.
    Huang S; Li Q; Liu H; Ma S; Long C; Li G; Yu Y
    Environ Int; 2022 Feb; 160():107074. PubMed ID: 34995968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary polycyclic aromatic hydrocarbon metabolites levels in a representative sample of the Spanish adult population: The BIOAMBIENT.ES project.
    Bartolomé M; Ramos JJ; Cutanda F; Huetos O; Esteban M; Ruiz-Moraga M; Calvo E; Pérez-Gómez B; González O; ; Castaño A
    Chemosphere; 2015 Sep; 135():436-46. PubMed ID: 25600323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetic analyses of naphthalene, fluorene, phenanthrene, and pyrene in humans after single oral administration.
    Choi JW; Kim M; Song G; Kho Y; Choi K; Shin MY; Kim S
    Sci Total Environ; 2023 Apr; 870():161899. PubMed ID: 36716884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of non-occupational exposure to polycyclic aromatic hydrocarbons through personal air sampling and urinary biomonitoring.
    Li Z; Mulholland JA; Romanoff LC; Pittman EN; Trinidad DA; Lewin MD; Sjödin A
    J Environ Monit; 2010 May; 12(5):1110-18. PubMed ID: 21491629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental and biological monitoring of exposures to PAHs and ETS in the general population.
    Aquilina NJ; Delgado-Saborit JM; Meddings C; Baker S; Harrison RM; Jacob P; Wilson M; Yu L; Duan M; Benowitz NL
    Environ Int; 2010 Oct; 36(7):763-71. PubMed ID: 20591483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and lifestyle factors affecting exposure to polycyclic aromatic hydrocarbons in the general population in a Middle Eastern area.
    Hoseini M; Nabizadeh R; Delgado-Saborit JM; Rafiee A; Yaghmaeian K; Parmy S; Faridi S; Hassanvand MS; Yunesian M; Naddafi K
    Environ Pollut; 2018 Sep; 240():781-792. PubMed ID: 29778814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbance of OH-PAH metabolites in urine induced by single PAH lab exposure.
    Yan P; Kong L; Qin T; Luo Z; Zhang X; Tie C
    Environ Sci Pollut Res Int; 2023 Aug; 30(39):91226-91236. PubMed ID: 37470974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary naphthalene and phenanthrene as biomarkers of occupational exposure to polycyclic aromatic hydrocarbons.
    Sobus JR; Waidyanatha S; McClean MD; Herrick RF; Smith TJ; Garshick E; Laden F; Hart JE; Zheng Y; Rappaport SM
    Occup Environ Med; 2009 Feb; 66(2):99-104. PubMed ID: 19017700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V).
    Murawski A; Roth A; Schwedler G; Schmied-Tobies MIH; Rucic E; Pluym N; Scherer M; Scherer G; Conrad A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2020 May; 226():113491. PubMed ID: 32092491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal biomonitoring of residents living near the waste incinerator of Turin: Polycyclic Aromatic Hydrocarbon metabolites after three years from the plant start-up.
    Iamiceli AL; Abate V; Bena A; De Filippis SP; De Luca S; Iacovella N; Farina E; Gandini M; Orengia M; De Felip E; Abballe A; Dellatte E; Ferri F; Fulgenzi AR; Ingelido AM; Ivaldi C; Marra V; Miniero R; Crosetto L; Procopio E; Salamina G
    Environ Pollut; 2022 Dec; 314():120199. PubMed ID: 36155226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokers.
    Ramsauer B; Sterz K; Hagedorn HW; Engl J; Scherer G; McEwan M; Errington G; Shepperd J; Cheung F
    Anal Bioanal Chem; 2011 Jan; 399(2):877-89. PubMed ID: 21046075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Monitoring of Occupational Exposure to Polycyclic Aromatic Hydrocarbons at an Electric Steel Foundry in Tunisia.
    Campo L; Hanchi M; Olgiati L; Polledri E; Consonni D; Zrafi I; Saidane-Mosbahi D; Fustinoni S
    Ann Occup Hyg; 2016 Jul; 60(6):700-16. PubMed ID: 27206821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an HPLC-MS/MS method for the simultaneous analysis of volatile organic compound metabolites, hydroxylated polycyclic aromatic hydrocarbons, and 8-hydroxy-2'-deoxyguanosine in human urine.
    Xu RF; Mei H; Chen L; Tang B; Lu QY; Cai FS; Yan X; Zheng J; Shen XT; Yu YJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123885. PubMed ID: 37725852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of polycyclic aromatic hydrocarbons in human diet - exposure and risk assessment to consumer health.
    Starski A; Kukielska A; Postupolski J
    Rocz Panstw Zakl Hig; 2021; 72(3):253-265. PubMed ID: 34553879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.